Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These ap...
Cote: | Libro Electrónico |
---|---|
Auteur principal: | Huml, Raymond A. (Auteur) |
Collectivité auteur: | SpringerLink (Online service) |
Format: | Électronique eBook |
Langue: | Inglés |
Publié: |
New York, NY :
Springer New York : Imprint: Springer,
2012.
|
Édition: | 1st ed. 2012. |
Collection: | SpringerBriefs in Pharmaceutical Science & Drug Development,
|
Sujets: | |
Accès en ligne: | Texto Completo |
Documents similaires
-
Dictionary of Pharmaceutical Medicine
par: Nahler, Gerhard
Publié: (2013) -
Pharmaceutical Nanotechnology Fundamentals and Practical Applications /
par: Demetzos, Costas
Publié: (2016) -
Pharmaceutical Biotechnology
Publié: (2009) -
Approaching China's Pharmaceutical Market A Fundamental Guide to Clinical Drug Development /
Publié: (2015) -
Pharmaceutical Biotechnology Fundamentals and Applications /
Publié: (2013)